Registry for health care research and quality assurance in private oncological practices

Registry for health care research and quality assurance in private oncological practices - ONCOReg

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004818

Enrollment

35000

Registered

2013-04-26

Start date

2013-02-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oncological and hematological diseases C00-D48

Interventions

Group 1: Data from patients with oncological or hematological disease are recorded in a questionnaire structured by history, the course of therapy and final survey . Follow-up data will be documented

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patient with confirmed oncological / hematological diagnosis - At least one oncological treatment - Beginning of documented therapy must not be longer than 10 months. - Declaration of consent

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
The primary objective is the acquisition and representation of real-life treatment in the outpatient sector. Recorded variables are defined in the common single oncological basic data set of ADT /GEKID. Additionally, data of therapy regime and its change over time is collected. The entire therapy course of a Patient will be collected from diagnosis until death or for a five year period in adjuvant therapies each patient history including all therapies of a patient. The following epidemiological surveys should be specified ubiquitously: - Relative survival of cancer patients in Germany - Penetration guideline-based therapies in oncology outpatient practice - Definition of reference- or metadata Furthermore, the possibility of defining reference intervals for measures (quality indicators) that could be used as the basis for quality management systems should be analyzed.	—

Measure

Time frame

The primary objective is the acquisition and representation of real-life treatment in the outpatient sector. Recorded variables are defined in the common single oncological basic data set of ADT /GEKID. Additionally, data of therapy regime and its change over time is collected. The entire therapy course of a Patient will be collected from diagnosis until death or for a five year period in adjuvant therapies each patient history including all therapies of a patient. The following epidemiological surveys should be specified ubiquitously: - Relative survival of cancer patients in Germany - Penetration guideline-based therapies in oncology outpatient practice - Definition of reference- or metadata Furthermore, the possibility of defining reference intervals for measures (quality indicators) that could be used as the basis for quality management systems should be analyzed.

—

Secondary

Measure	Time frame
not relevant	—

Countries

Germany

Contacts

Public ContactMarkus Kersting

rgb Onkologisches Management GmbH

markus.kersting@rgb-onkologie.de05101-991354

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026